Tuesday, August 28, 2018

Oncolytic Virotherapy and Multiple Myeloma by Nahla AM Hamed in BJSTR

Abstract

OV immunotherapy is an important emerging cancer treatment modality which uses native or genetically modified viruses to destroy cancers. MM is perhaps the ideal malignancy to target using OVs because of the virus permissivity of neoplastic plasma cells and the diseaseassociated immune paresis. OVs have the potential to mediate both tumor debulking and residual disease elimination avoiding the complex and prolonged current therapy for multiple myeloma.




No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Pocus in Covid-19 Patients with Vascular Complications: What Have We Learnt from the Pandemic?

  Pocus in Covid-19 Patients with Vascular Complications: What Have We Learnt from the Pandemic? Introduction The most common complication o...